Oxaliplatin, fluorouracil and leucovorin (FOLFOX4) as first line treatment in elderly patients with metastatic colorectal cancer

被引：0
|
作者：
Ratti, R.
Coccorullo, Z.
Addarno, G.
Venturino, A.
Colloca, G.
Guarneri, D.
Carnpora, E.
机构：
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：87 / 87
页数：1
相关论文
共 50 条
  • [1] Oxaliplatin and infused fluorouracil plus leucovorin (FOLFOX4) as first line treatment in elderly patients with metastatic colorectal cancer patients
    Addamo, G.
    Coccorullo, Z.
    Venturino, A.
    Colloca, G.
    Ratti, R.
    Guarneri, D.
    Campora, E.
    ANNALS OF ONCOLOGY, 2006, 17 : XI45 - XI45
  • [2] Feasibility of oxaliplatin and infusional fluorouracil/leucovorin (FOLFOX4) for Japanese patients with unresectable metastatic colorectal cancer
    Fuse, Nozomu
    Doi, Toshihiko
    Ohtsu, Atsushi
    Takeuchi, Satoshi
    Kojima, Takashi
    Taku, Keisei
    Tahara, Makoto
    Muto, Manabu
    Asaka, Masahiro
    Yoshida, Shigeaki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2007, 37 (06) : 434 - 439
  • [3] Oxaliplatin,Fluorouracil and Leucovorin (FOLFOX) as First-line Chemotherapy for Metastatic or Recurrent Colorectal Cancer Patients
    Bing Han Ruihua Xu Yanxia Shi Huiyan Luo Xiaojuan Xiang Yuhong Li Li Zhang Tongyu Lin Youjian HeDepartment of Medical Oncology
    Chinese Journal of Clinical Oncology, 2007, (06) : 397 - 400
  • [4] Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study
    Douillard, Jean-Yves
    Siena, Salvatore
    Cassidy, James
    Tabernero, Josep
    Burkes, Ronald
    Barugel, Mario
    Humblet, Yves
    Bodoky, Gyoergy
    Cunningham, David
    Jassem, Jacek
    Rivera, Fernando
    Kocakova, Ilona
    Ruff, Paul
    Blasinska-Morawiec, Maria
    Smakal, Martin
    Canon, Jean-Luc
    Rother, Mark
    Oliner, Kelly S.
    Wolf, Michael
    Gansert, Jennifer
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (31) : 4697 - 4705
  • [5] Bolus fluorouracil and leucovorin with oxaliplatin as first-line treatment in metastatic colorectal cancer
    Ravaioli, A
    Marangolo, M
    Pasquini, E
    Rossi, A
    Amadori, D
    Cruciani, G
    Tassinari, D
    Oliverio, G
    Giovanis, P
    Turci, D
    Zumaglini, F
    Nicolini, M
    Panzini, I
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (10) : 2545 - 2550
  • [6] Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer
    Bokemeyer, Carsten
    Bondarenko, Igor
    Makhson, Anatoly
    Hartmann, Joerg T.
    Aparicio, Jorge
    de Braud, Filippo
    Donea, Serban
    Ludwig, Heinz
    Schuch, Gunter
    Stroh, Christopher
    Loos, Anja H.
    Zubel, Angela
    Koralewski, Piotr
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (05) : 663 - 671
  • [7] FOLFOX4 in the treatment of metastatic colorectal cancer in elderly patients: A prospective study
    Berretta, Massimiliano
    Cappellani, Alessandro
    Fiorica, Francesco
    Nasti, Guglielmo
    Frustaci, Sergio
    Fisichella, Rossella
    Bearz, Alessandra
    Talamini, Renato
    Lleshi, Arben
    Tambaro, Rosa
    Cocciolo, Alessandro
    Ristagno, Maurizio
    Bolognese, Antonio
    Basile, Francesco
    Meneguzzo, Nereo
    Berretta, Salvatore
    Tirelli, Umberto
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2011, 52 (01) : 89 - 93
  • [8] Sorafenib in Combination with Oxaliplatin, Leucovorin, and Fluorouracil (Modified FOLFOX6) as First-line Treatment of Metastatic Colorectal Cancer: The RESPECT Trial
    Tabernero, Josep
    Garcia-Carbonero, Rocio
    Cassidy, James
    Sobrero, Alberto
    Van Cutsem, Eric
    Koehne, Claus-Henning
    Tejpar, Sabine
    Gladkov, Oleg
    Davidenko, Irina
    Salazar, Ramon
    Vladimirova, Liubov
    Cheporov, Sergey
    Burdaeva, Olga
    Rivera, Fernando
    Samuel, Leslie
    Bulavina, Irina
    Potter, Vanessa
    Chang, Yu-Lin
    Lokker, Nathalie A.
    O'Dwyer, Peter J.
    CLINICAL CANCER RESEARCH, 2013, 19 (09) : 2541 - 2550
  • [9] Bevacizumab plus oxaliplatin (LOHP), leukovorin (LV)/5-fluorouracil (5-FU) (FOLFOX4) as first line treatment of patients with metastatic colorectal cancer(MCC)
    Emmanouilides, C.
    Sfakiotaki, G.
    Souglakos, J.
    Mavroudis, D.
    Androulakis, N.
    Kavlaki, A.
    Kotsakis, A.
    Diamandidou, E.
    Touroutoglou, N.
    Georgoulias, V
    ANNALS OF ONCOLOGY, 2006, 17 : 70 - 71
  • [10] Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer
    Ducreux, Michel
    Bennouna, Jaafar
    Hebbar, Mohamed
    Ychou, Marc
    Lledo, Gerard
    Conroy, Thierry
    Adenis, Antoine
    Faroux, Roger
    Rebischung, Christine
    Bergougnoux, Loic
    Kockler, Leila
    Douillard, Jean-Yves
    INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (03) : 682 - 690
12345